Berkshire Bank Novartis Ag Transaction History

Berkshire Bank

$428 Million
Q2 2025

A detailed history of Berkshire Bank transactions in Novartis Ag stock. As of the latest transaction made, Berkshire Bank holds 3,113 shares of NVS stock, worth $371,412. This represents 0.09% of its overall portfolio holdings.

Number of Shares

3,113

Previous 3,462 10.08%

Holding current value

$371,412

Previous $385,000 2.34%

% of portfolio

0.09%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 09, 2025	SELL	$101.96 - $121.01 $35,584 - $42,232	-349 Reduced 10.08%	3,113 $376,000
Q1 2025 Apr 17, 2025	SELL	$97.14 - $115.57 $15,930 - $18,953	-164 Reduced 4.52%	3,462 $385,000
Q4 2024 Jan 22, 2025	SELL	$96.78 - $117.18 $57,680 - $69,839	-596 Reduced 14.12%	3,626 $352,000
Q3 2024 Oct 18, 2024	SELL	$106.13 - $120.89 $20,483 - $23,331	-193 Reduced 4.37%	4,222 $485,000
Q2 2024 Jul 12, 2024	SELL	$92.57 - $107.37 $43,507 - $50,463	-470 Reduced 9.62%	4,415 $470,000
Q1 2024 Apr 24, 2024	BUY	$95.27 - $108.47 $38,298 - $43,604	402 Added 8.97%	4,885 $472,000
Q4 2023 Jan 22, 2024	SELL	$92.27 - $101.54 $43,459 - $47,825	-471 Reduced 9.51%	4,483 $452,000
Q3 2023 Nov 01, 2023	SELL	$94.73 - $105.13 $11,367 - $12,615	-120 Reduced 2.36%	4,954 $504,000
Q2 2023 Jul 12, 2023	BUY	$92.52 - $104.91 $8,141 - $9,232	88 Added 1.76%	5,074 $512,000
Q1 2023 Apr 11, 2023	SELL	$80.03 - $92.81 $121,885 - $141,349	-1,523 Reduced 23.4%	4,986 $458,000
Q4 2022 Feb 02, 2023	SELL	$75.55 - $92.52 $357,804 - $438,174	-4,736 Reduced 42.12%	6,509 $590,000
Q3 2022 Nov 07, 2022	SELL	$74.61 - $87.26 $47,377 - $55,410	-635 Reduced 5.35%	11,245 $855,000
Q2 2022 Jul 15, 2022	SELL	$80.52 - $93.75 $12,722 - $14,812	-158 Reduced 1.31%	11,880 $1.01 Million
Q1 2022 Apr 21, 2022	SELL	$80.11 - $90.62 $99,416 - $112,459	-1,241 Reduced 9.35%	12,038 $1.06 Million
Q4 2021 Jan 28, 2022	SELL	$79.7 - $88.13 $307,084 - $339,564	-3,853 Reduced 22.49%	13,279 $1.16 Million
Q3 2021 Oct 14, 2021	SELL	$81.78 - $95.14 $102,961 - $119,781	-1,259 Reduced 6.85%	17,132 $1.4 Million
Q2 2021 Jul 26, 2021	SELL	$85.24 - $94.15 $747,043 - $825,130	-8,764 Reduced 32.27%	18,391 $1.68 Million
Q1 2021 Apr 19, 2021	SELL	$83.5 - $98.47 $68,303 - $80,548	-818 Reduced 2.92%	27,155 $2.32 Million
Q4 2020 Jan 27, 2021	BUY	$78.07 - $94.43 $20,844 - $25,212	267 Added 0.96%	27,973 $2.64 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $2.28 Million - $2.52 Million	27,706 New	27,706 $2.41 Million

Others Institutions Holding NVS

# of Institutions

1,550

Shares Held

140M

Call Options Held

1.69M

Put Options Held

1.87M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $257B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Bank, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Bank with notifications on news.

Account